[SCHEDULE 13G] Ocugen, Inc. Passive Investment Disclosure (>5%)
Filing Impact
Filing Sentiment
Form Type
SCHEDULE 13G
Rhea-AI Filing Summary
Ocugen, Inc. disclosed a Schedule 13G showing that Millennium Management LLC, Millennium Group Management LLC and Israel A. Englander report shared voting and dispositive power over 17,074,584 shares of Common Stock (CUSIP 67577C105), representing 5.2% of the class. The filing is a joint filing and is signed April 13, 2026.
Positive
- None.
Negative
- None.
Key Figures
Shared voting power: 17,074,584 shares
Shared dispositive power: 17,074,584 shares
Percent of class: 5.2%
+3 more
6 metrics
Shared voting power
17,074,584 shares
reported shared voting power in Schedule 13G
Shared dispositive power
17,074,584 shares
reported shared dispositive power in Schedule 13G
Percent of class
5.2%
percent of outstanding common stock reported on cover page
Filing signature date
04/13/2026
Schedule 13G signatures
Cover date
04/09/2026
date shown on cover information
CUSIP
67577C105
Ocugen Common Stock CUSIP listed on filing
Key Terms
Shared Voting Power, Beneficially owned, Joint Filing Agreement
3 terms
Beneficially owned regulatory
"Amount beneficially owned: See response to Item 9 on each cover page."
Beneficially owned describes securities or assets where a person has the economic rights and control—such as the right to receive dividends and to direct voting—even if legal title is held in another name. Think of it like having the keys and using a car that’s registered to someone else: you get the benefits and make decisions. Investors care because beneficial ownership reveals who truly controls value and voting power, affecting corporate decisions and takeover dynamics.
Joint Filing Agreement legal
"Joint Filing Agreement, dated as of April 13, 2026"